BRIANNE COOK: Open Payments
NPI 1407881618 · LAWRENCE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$281 in 16 payments from 11 companies in 2025. Trend: 2023 $487 · 2024 $15 · 2025 $281
Food & beverage: $281
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $53 |
| ABBVIE INC. | 2 | $39 |
| Lilly USA, LLC | 2 | $32 |
| PFIZER INC. | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $21 |
| Ardelyx, Inc. | 1 | $20 |
| Gilead Sciences, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: MOUNJARO, PREVNAR 20, UBRELVY, Symbravo, The Cologuard Plus Collection Kit, Wegovy, IBSRELA, Ozempic.
Industry payments across KS — which companies pay providers there.
